MedTrace Logo

The Evaluation of Thrombogenicity in Patients Undergoing WATCHMAN Left Atrial Appendage Closure Trial

NCT03040622 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 35

Last updated 2024-03-29

Study results available
· View outcomes & findings →

Summary

This study will evaluate thrombogenicity in patients undergoing left atrial appendage closure using the WATCHMAN device. Parameters of thrombosis and platelet function, as well as other bio-markers, will be measure before, during, and after WATCHMAN implantation at several follow up visits.

Conditions

  • Left Atrial Appendage Closure
  • WATCHMAN Device Implantation

Interventions

DEVICE

WATCHMAN Left Atrial Appendage Closure

WATCHMAN Left Atrial Appendage Closure

Sponsors & Collaborators

  • Boston Scientific Corporation

    collaborator INDUSTRY

  • Inova Health Care Services

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-01
Primary Completion
2019-10-15
Completion
2019-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03040622 on ClinicalTrials.gov